Financings in Brief: PerSeptive Biosystems
This article was originally published in The Gray Sheet
PerSeptive Biosystems: Redeems 1,000 shares of preferred stock held by Millipore for 1.25 mil. shares of common stock valued at $8 each. The preferred stock was issued in connection with the acquisition of Millipore's BioSearch division by PerSeptive in August 1994 ("The Gray Sheet" July 18, 1994, In Brief). The payment is valued at $10 mil...
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.